Cargando…

Oral manifestations in SARS-CoV-2 infection

BACKGROUND: We aimed to evaluate the prevalence of predisposing factors and oral manifestations in SARS-CoV-2 infection. MATERIAL AND METHODS: 204 SARS-CoV-2 positive patients were included in the study. Questions regarding the systemic, periodontal health, oral hygiene habits, common symptoms and,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuter, Gulay, Yerebakan, Mukaddes, Celik, Bulent, Kara, Gulsah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271340/
https://www.ncbi.nlm.nih.gov/pubmed/35717616
http://dx.doi.org/10.4317/medoral.25259
_version_ 1784744657969741824
author Tuter, Gulay
Yerebakan, Mukaddes
Celik, Bulent
Kara, Gulsah
author_facet Tuter, Gulay
Yerebakan, Mukaddes
Celik, Bulent
Kara, Gulsah
author_sort Tuter, Gulay
collection PubMed
description BACKGROUND: We aimed to evaluate the prevalence of predisposing factors and oral manifestations in SARS-CoV-2 infection. MATERIAL AND METHODS: 204 SARS-CoV-2 positive patients were included in the study. Questions regarding the systemic, periodontal health, oral hygiene habits, common symptoms and, oral manifestations of COVID-19 such as oral lesions, and dry mouth were included in the survey. The Visual Analogue Scale (VAS) was used. RESULTS: 47.5% of individuals had various systemic diseases. Dry mouth (44.2%) and oral lesions (22.4%) were the most common oral manifestations in COVID-19 patients. Also, dry mouth had the highest VAS score. The most common oral lesion locations were buccal mucosa (15.2%) and tongue (10.8%). The majority of participants (142 patients) were affected by taste disorders. Patients who received periodontal treatment before SARS-CoV-2 infection reported fewer oral complaint and manifestations than those who did not receive periodontal therapy (p=0.032). There was no statistically significant difference between males and females on the presence of any oral manifestations, and taste disorders. CONCLUSIONS: Our results showed that SARS-CoV-2 could cause oral manifestations. However various predisposing factors may be part of the etiology and promote oral findings. Key words:SARS-CoV-2, COVID-19, xrestomia, dysgeusia, oral manifestation.
format Online
Article
Text
id pubmed-9271340
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-92713402022-07-11 Oral manifestations in SARS-CoV-2 infection Tuter, Gulay Yerebakan, Mukaddes Celik, Bulent Kara, Gulsah Med Oral Patol Oral Cir Bucal Research BACKGROUND: We aimed to evaluate the prevalence of predisposing factors and oral manifestations in SARS-CoV-2 infection. MATERIAL AND METHODS: 204 SARS-CoV-2 positive patients were included in the study. Questions regarding the systemic, periodontal health, oral hygiene habits, common symptoms and, oral manifestations of COVID-19 such as oral lesions, and dry mouth were included in the survey. The Visual Analogue Scale (VAS) was used. RESULTS: 47.5% of individuals had various systemic diseases. Dry mouth (44.2%) and oral lesions (22.4%) were the most common oral manifestations in COVID-19 patients. Also, dry mouth had the highest VAS score. The most common oral lesion locations were buccal mucosa (15.2%) and tongue (10.8%). The majority of participants (142 patients) were affected by taste disorders. Patients who received periodontal treatment before SARS-CoV-2 infection reported fewer oral complaint and manifestations than those who did not receive periodontal therapy (p=0.032). There was no statistically significant difference between males and females on the presence of any oral manifestations, and taste disorders. CONCLUSIONS: Our results showed that SARS-CoV-2 could cause oral manifestations. However various predisposing factors may be part of the etiology and promote oral findings. Key words:SARS-CoV-2, COVID-19, xrestomia, dysgeusia, oral manifestation. Medicina Oral S.L. 2022-07 2022-06-19 /pmc/articles/PMC9271340/ /pubmed/35717616 http://dx.doi.org/10.4317/medoral.25259 Text en Copyright: © 2022 Medicina Oral S.L. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tuter, Gulay
Yerebakan, Mukaddes
Celik, Bulent
Kara, Gulsah
Oral manifestations in SARS-CoV-2 infection
title Oral manifestations in SARS-CoV-2 infection
title_full Oral manifestations in SARS-CoV-2 infection
title_fullStr Oral manifestations in SARS-CoV-2 infection
title_full_unstemmed Oral manifestations in SARS-CoV-2 infection
title_short Oral manifestations in SARS-CoV-2 infection
title_sort oral manifestations in sars-cov-2 infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271340/
https://www.ncbi.nlm.nih.gov/pubmed/35717616
http://dx.doi.org/10.4317/medoral.25259
work_keys_str_mv AT tutergulay oralmanifestationsinsarscov2infection
AT yerebakanmukaddes oralmanifestationsinsarscov2infection
AT celikbulent oralmanifestationsinsarscov2infection
AT karagulsah oralmanifestationsinsarscov2infection